Status:
COMPLETED
Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Osteoarticular Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: One of the leading causes of peri-operative osteoarticular infections (OAI) is Staphylococcus aureus. Treatment usually requires surgical debridement in association with appropriate antib...
Detailed Description
Background: One of the leading causes of peri-operative osteoarticular infections (OAI) is Staphylococcus aureus. Treatment usually requires surgical debridement in association with appropriate antib...
Eligibility Criteria
Inclusion
- subject over 18 years with a IOA with GERME sensitivity to three antibiotics,
- Patient in orthopedic unit of HEGP,
- Patient who received and understood the information and who signed consent,
Exclusion
- Known allergy to one of three antibiotics and / or excipients,
- Pregnancy or during lactation,
- Congenital galactosemia, malabsorption of glucose and galactose, or lactase deficiency,
- History of tendinopathy with fluoroquinolones,
- G6PD deficiency,
- porphyria,
- subject receiving a protease inhibitor,
- subject receiving anticoagulants
- Malabsorption syndrome,
- subject unable to follow the protocol (organizational problem, intellectual disability, ...).
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01500837
Start Date
October 1 2010
End Date
October 1 2011
Last Update
September 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Paris
Paris, France, 75015